EPS Forecast
Revenue Forecast
EX-99.1
2
earningsreleaseq4fy23.htm
EX-99.1
Document
Exhibit 99.1
Allegro MicroSystems Reports Fourth Quarter and Fiscal Year 2023 Results
--
Fourth Quarter Sales increased by 35% and GAAP Earnings Per Share (EPS) increased by 138% Year-over-Year --
-- Annual Sales increased by 27% and GAAP EPS increased by 56% Year-over-Year --
-- Continued Growth in Automotive and Industrial Drove Record Sales for the
Fourth Quarter & Full Year --
Manchester, NH, May 10, 2023 – Allegro MicroSystems, Inc. (“Allegro” or the “Company”) (Nasdaq:ALGM), a global leader in power and sensing semiconductor solutions for motion control and energy efficient systems, today announced financial results for its fourth quarter and fiscal year 2023 which ended March 31, 2023.
“We delivered a strong finish to fiscal year 2023, including record fourth quarter sales of $269 million, up 35% year-over-year. We also achieved record non-GAAP diluted earnings per share of $0.37, an increase of more than 75% year-over-year,” said Vineet Nargolwala, President and CEO of Allegro MicroSystems. “Solid fourth quarter results contributed to record fiscal year 2023 sales of $974 million, up 27% year-over-year. We saw significantly increased design win momentum in fiscal year 2023 with approximately two-thirds of our wins coming from strategic growth areas including e-Mobility and Industrial. E-Mobility increased to 43% of fiscal year 2023 Automotive sales, up from 36% in fiscal year 2022. The results in the fourth quarter and throughout the past year demonstrate further execution of our strategy.”
Fourth Quarter and Full Fiscal Year 2023 Financial Highlights:
| In thousands, except per share data | Quarter | Year | |||||||||||||||||||||||||||
| Q4 FY23 | Q3 FY23 | Q4 FY22 | FY23 | FY22 | |||||||||||||||||||||||||
| Net Sales | |||||||||||||||||||||||||||||
| Automotive | $ | 182,376 | $ | 168,056 | $ | 141,213 | $ | 657,479 | $ | 531,564 | |||||||||||||||||||
| Industrial | 57,990 | 50,399 | 34,654 | 196,705 | 133,187 | ||||||||||||||||||||||||
| Other | 29,079 | 30,334 | 24,426 | 119,469 | 103,923 | ||||||||||||||||||||||||
| Total net sales | $ | 269,445 | $ | 248,789 | $ | 200,293 | $ | 973,653 | $ | 768,674 | |||||||||||||||||||
| GAAP Financial Measures | |||||||||||||||||||||||||||||
| Gross margin % | 56.8 | % | 57.3 | % | 54.7 | % | 56.1 | % | 53.0 | % | |||||||||||||||||||
| Operating margin % | 23.4 | % | 26.4 | % | 15.1 | % | 20.8 | % | 17.8 | % | |||||||||||||||||||
| Diluted EPS | $ | 0.32 | $ | 0.33 | $ | 0.13 | $ | 0.97 | $ | 0.62 | |||||||||||||||||||
| Non-GAAP Financial Measures | |||||||||||||||||||||||||||||
| Gross margin % | 57.8 | % | 58.0 | % | 55.6 | % | 56.8 | % | 54.1 | % | |||||||||||||||||||
| Operating margin % | 30.2 | % | 30.3 | % | 23.2 | % | 28.6 | % | 23.2 | % | |||||||||||||||||||
| Diluted EPS | $ | 0.37 | $ | 0.35 | $ | 0.21 | $ | 1.28 | $ | 0.78 | |||||||||||||||||||
Business Outlook
For the first quarter ending June 30, 2023, the Company expects total sales to be in the range of $270 million to $280 million. The company also estimates the following results on a non-GAAP basis:
•Gross margin is expected to be approximately 56%
•Operating expenses are anticipated to be between 26% and 27% of sales
•Earnings per diluted share are expected to be in the range of $0.35 to $0.39
Allegro has not provided a reconciliation of its first fiscal quarter outlook for non-GAAP gross margin, non-GAAP operating expenses and non-GAAP earnings per diluted share because estimates of all of the reconciling items cannot be provided without unreasonable efforts. It is difficult to reasonably provide a forward-looking estimate between such forward-looking non-GAAP measures and the comparable forward-looking GAAP measures. Certain factors that are materially significant to Allegro’s ability to estimate these items are out of its control and/or cannot be reasonably predicted.
Earnings Webcast
A webcast will be held on Thursday, May 11, 2023 at 8:30 a.m. Eastern time. Vineet Nargolwala, President and Chief Executive Officer, and Derek D’Antilio, Chief Financial Officer, will discuss Allegro’s business and financial results.
The webcast will be available on the Investor Relations section of the Company’s website at investors.allegromicro.com. A recording of the webcast will be posted in the same location shortly after the call concludes and will be available for at least 90 days.
About Allegro MicroSystems
Allegro MicroSystems is a leading global designer, developer, fabless manufacturer and marketer of sensor integrated circuits (“ICs”) and application-specific analog power ICs enabling emerging technologies in the automotive and industrial markets. Allegro’s diverse product portfolio provides efficient and reliable solutions for the electrification of vehicles, automotive ADAS safety features, automation for Industry 4.0 and power saving technologies for data centers and green energy applications.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including, without limitation, statements regarding our expected financial performance for our first fiscal quarter ending June 30, 2023. In some cases, you can identify forward-looking statements by terms such as “anticipate,” “believe,” “could,” “expect,” “should,” “plan,” “intend,” “estimate,” “target,” “mission,” “may,” “will,” “would,” “project,” “predict,” “contemplate,” “potential,” or the negative thereof and similar words and expressions.
Forward-looking statements are based on management’s current expectations, beliefs and assumptions and on information currently available to us. Such statements are subject to a number of known and unknown risks, uncertainties and assumptions, and actual results may differ materially from those expressed or implied in the forward-looking statements due to various important factors, including, but not limited to: downturns or volatility in general economic conditions, including as a result of the COVID-19 pandemic, particularly in the automotive market; our ability to compete effectively, expand our market share and increase our net sales and profitability; our reliance on a limited number of third-party wafer fabrication facilities and suppliers of other materials; our failure to adjust purchase commitments, supply chain volume and inventory management based on changing market conditions or customer demand; shifts in our product mix or customer mix, which could negatively impact our gross margin; the cyclical nature of the analog semiconductor industry; our ability to compensate for decreases in average selling prices of our products and increases in input costs; increases in inflation rates or sustained periods of inflation in the markets in which we operate; any disruptions at our primary third-party wafer fabrication facilities; our ability to manage any sustained yield problems or other delays at our third-party wafer fabrication semiconductor facilities or in the final assembly and test of our products; our ability to fully realize the benefits of past and potential future initiatives designed to improve our competitiveness, growth and profitability; our ability to accurately predict our quarterly net sales and operating results; our dependence on manufacturing operations in the Philippines; our reliance on distributors to
generate sales; COVID-19 induced lock-downs and suppression on our supply chain and customer demand; our ability to develop new product features or new products in a timely and cost-effective manner; our ability to manage growth; any slowdown in the growth of our end markets; the loss of one or more significant customers; our ability to meet customers’ quality requirements; uncertainties related to the design win process and our ability to recover design and development expenses and to generate timely or sufficient net sales or margins; changes in government trade policies, including the imposition of tariffs and export restrictions; our exposures to warranty claims, product liability claims and product recalls; our dependence on international customers and operations; the availability of rebates, tax credits and other financial incentives on end-user demands for certain products; risks related to governmental regulation and other legal obligations, including privacy, data protection, information security, consumer protection, environmental and occupational health and safety, anti-corruption and anti-bribery, and trade controls; the volatility of currency exchange rates; our indebtedness may limit our flexibility to operate our business; our ability to retain key and highly skilled personnel; our ability to protect our proprietary technology and inventions through patents or trade secrets; our ability to commercialize our products without infringing third-party intellectual property rights; disruptions or breaches of our information technology systems or those of our third-party service providers; our principal stockholders have substantial control over us; the inapplicability of the “corporate opportunity” doctrine to any director or stockholder who is not employed by us; the dilutive impact on the price of our shares upon future issuance by us or future sales by our stockholders; our lack of intent to declare or pay dividends for the foreseeable future; anti-takeover provisions in our organizational documents and under the General Corporation Law of the State of Delaware; the exclusive forum provision in our Certificate of Incorporation for disputes with stockholders; our inability to design, implement or maintain effective internal control over financial reporting; changes in tax rates or the adoption of new tax legislation; and other important factors discussed under the caption “Risk Factors” in our Annual Report on Form 10-K filed with the Securities and Exchange Commission (“SEC”) on May 18, 2022, as amended by Amendment No. 1 on Form 10-K/A filed with the SEC on August 29, 2022, as any such factors may be updated or supplemented from time to time in our other filings with the SEC, which are accessible on the SEC’s website at www.sec.gov and the Investors Relations page of our website at investors.allegromicro.com.
All forward-looking statements speak only as of the date of this press release and, except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise.
ALLEGRO MICROSYSTEMS, INC.
CONSOLIDATED STATEMENT OF OPERATIONS
CONSOLIDATED STATEMENT OF OPERATIONS
(in thousands, except share and per share amounts)
| Three-Month Period Ended | Fiscal Year Ended | ||||||||||||||||||||||||||||
| March 31, 2023 | March 25, 2022 | March 31, 2023 | March 25, 2022 | ||||||||||||||||||||||||||
| (Unaudited) | (Unaudited) | (Unaudited) | |||||||||||||||||||||||||||
| Net sales | $ | 240,534 | $ | 163,559 | $ | 812,890 | $ | 619,861 | |||||||||||||||||||||
| Net sales to related party | 28,911 | 36,734 | 160,763 | 148,813 | |||||||||||||||||||||||||
| Total net sales | 269,445 | 200,293 | 973,653 | 768,674 | |||||||||||||||||||||||||
| Cost of goods sold | 100,585 | 72,044 | 348,390 | 286,855 | |||||||||||||||||||||||||
| Cost of goods sold to related party | 15,771 | 18,646 | 79,184 | 74,359 | |||||||||||||||||||||||||
| Gross profit | 153,089 | 109,603 | 546,079 | 407,460 | |||||||||||||||||||||||||
| Operating expenses: | |||||||||||||||||||||||||||||
| Research and development | 41,833 | 32,432 | 150,850 | 121,873 | |||||||||||||||||||||||||
| Selling, general and administrative | 48,252 | 46,822 | 194,722 | 150,937 | |||||||||||||||||||||||||
| Change in fair value of contingent consideration | (100) | 100 | (2,800) | (2,000) | |||||||||||||||||||||||||
| Total operating expenses | 89,985 | 79,354 | 342,772 | 270,810 | |||||||||||||||||||||||||
| Operating income | 63,104 | 30,249 | 203,307 | 136,650 | |||||||||||||||||||||||||
| Other income (expense): | |||||||||||||||||||||||||||||
| Interest expense | (755) | (418) | (2,336) | (2,499) | |||||||||||||||||||||||||
| Interest income | 580 | 1,125 | 1,724 | 1,442 | |||||||||||||||||||||||||
| Foreign currency transaction gain (loss) | (1,617) | (513) | 980 | (568) | |||||||||||||||||||||||||
| (Loss) income in earnings of equity investment | (703) | 215 | (406) | 1,007 | |||||||||||||||||||||||||
| Unrealized gains (losses) on marketable securities | 7,476 | (760) | 7,471 | 3,722 | |||||||||||||||||||||||||
| Other, net | (164) | 258 | 606 | 992 | |||||||||||||||||||||||||
| Income before income taxes | 67,921 | 30,156 | 211,346 | 140,746 | |||||||||||||||||||||||||
| Income tax provision | 5,909 | 4,504 | 23,852 | 21,191 | |||||||||||||||||||||||||
| Net income | 62,012 | 25,652 | 187,494 | 119,555 | |||||||||||||||||||||||||
| Net income attributable to non-controlling interests | 35 | 36 | 137 | 148 | |||||||||||||||||||||||||
| Net income attributable to Allegro MicroSystems, Inc. | $ | 61,977 | $ | 25,616 | $ | 187,357 | $ | 119,407 | |||||||||||||||||||||
| Net income attributable to Allegro MicroSystems, Inc. per share: | |||||||||||||||||||||||||||||
| Basic | $ | 0.32 | $ | 0.13 | $ | 0.98 | $ | 0.63 | |||||||||||||||||||||
| Diluted | $ | 0.32 | $ | 0.13 | $ | 0.97 | $ | 0.62 | |||||||||||||||||||||
| Weighted average shares outstanding: | |||||||||||||||||||||||||||||
| Basic | 191,519,850 | 189,997,738 | 191,197,452 | 189,748,427 | |||||||||||||||||||||||||
| Diluted | 194,993,241 | 192,125,252 | 193,688,102 | 191,811,205 | |||||||||||||||||||||||||
Supplemental Schedule of Total Net Sales
The following table summarizes total net sales by market within the Company’s unaudited consolidated statements of operations:
| Three-Month Period Ended | Change | Fiscal Year Ended | Change | ||||||||||||||||||||||||||||||||||||||||||||
| March 31, 2023 | March 25, 2022 | Amount | % | March 31, 2023 | March 25, 2022 | Amount | % | ||||||||||||||||||||||||||||||||||||||||
| (Dollars in thousands) | |||||||||||||||||||||||||||||||||||||||||||||||
| Automotive | $ | 182,376 | $ | 141,213 | $ | 41,163 | 29.1 | % | $ | 657,479 | $ | 531,564 | $ | 125,915 | 23.7 | % | |||||||||||||||||||||||||||||||
| Industrial | 57,990 | 34,654 | 23,336 | 67.3 | % | 196,705 | 133,187 | 63,518 | 47.7 | % | |||||||||||||||||||||||||||||||||||||
| Other | 29,079 | 24,426 | 4,653 | 19.0 | % | 119,469 | 103,923 | 15,546 | 15.0 | % | |||||||||||||||||||||||||||||||||||||
| Total net sales | 269,445 | 200,293 | 69,152 | 34.5 | % | 973,653 | 768,674 | 204,979 | 26.7 | % | |||||||||||||||||||||||||||||||||||||
ALLEGRO MICROSYSTEMS, INC.
CONSOLIDATED BALANCE SHEETS
(in thousands, except share and per share amounts)
| March 31, 2023 | March 25, 2022 | ||||||||||
| (Unaudited) | |||||||||||
| Assets | |||||||||||
| Current assets: | |||||||||||
| Cash and cash equivalents | $ | 351,576 | $ | 282,383 | |||||||
| Restricted cash | 7,129 | 7,416 | |||||||||
| Trade accounts receivable, net of provision for expected credit losses | 111,290 | 87,359 | |||||||||
| Trade and other accounts receivable due from related party | 13,494 | 27,360 | |||||||||
| Accounts receivable - other | 1,943 | 4,144 | |||||||||
| Inventories | 151,301 | 86,160 | |||||||||
| Prepaid expenses and other current assets | 25,346 | 14,995 | |||||||||
| Current portion of related party note receivable | 3,750 | 1,875 | |||||||||
| Total current assets | 665,829 | 511,692 | |||||||||
| Property, plant and equipment, net | 263,099 | 210,028 | |||||||||
| Operating lease right-of-use assets | 16,866 | 16,049 | |||||||||
| Deferred income tax assets | 50,359 | 17,967 | |||||||||
| Goodwill | 27,691 | 20,009 | |||||||||
| Intangible assets, net | 52,378 | 35,970 | |||||||||
| Related party note receivable, less current portion | 8,438 | 5,625 | |||||||||
| Equity investment in related party | 27,265 | 27,671 | |||||||||
| Other assets, net | 69,230 | 47,609 | |||||||||
| Total assets | $ | 1,181,155 | $ | 892,620 | |||||||
| Liabilities, Non-Controlling Interests and Stockholders' Equity | |||||||||||
| Current liabilities: | |||||||||||
| Trade accounts payable | $ | 56,256 | $ | 29,836 | |||||||
| Amounts due to related parties | 9,682 | 5,222 | |||||||||
| Accrued expenses and other current liabilities | 94,894 | 65,459 | |||||||||
| Current portion of operating lease liabilities | 4,493 | 3,706 | |||||||||
| Total current liabilities | 165,325 | 104,223 | |||||||||
| Obligations due under Senior Secured Credit Facilities | 25,000 | 25,000 | |||||||||
| Operating lease liabilities, less current portion | 13,048 | 12,748 | |||||||||
| Other long-term liabilities | 10,967 | 15,286 | |||||||||
| Total liabilities | 214,340 | 157,257 | |||||||||
| Commitments and contingencies | |||||||||||
| Stockholders' Equity: | |||||||||||
| Preferred Stock, $0.01 par value; 20,000,000 shares authorized, no shares issued or outstanding at March 31, 2023 and March 25, 2022 | — | — | |||||||||
| Common stock, $0.01 par value; 1,000,000,000 shares authorized, 191,754,292 shares issued and outstanding at March 31, 2023; 1,000,000,000 shares authorized, 190,473,595 issued and outstanding at March 25, 2022 | 1,918 | 1,905 | |||||||||
| Additional paid-in capital | 674,179 | 627,792 | |||||||||
| Retained earnings | 310,315 | 122,958 | |||||||||
| Accumulated other comprehensive loss | (20,784) | (18,448) | |||||||||
| Equity attributable to Allegro MicroSystems, Inc. | 965,628 | 734,207 | |||||||||
| Non-controlling interests | 1,187 | 1,156 | |||||||||
| Total stockholders' equity | 966,815 | 735,363 | |||||||||
| Total liabilities, non-controlling interests and stockholders' equity | $ | 1,181,155 | $ | 892,620 | |||||||
ALLEGRO MICROSYSTEMS, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
| Fiscal Year Ended | |||||||||||||||||
| March 31, 2023 | March 25, 2022 | ||||||||||||||||
| (Unaudited) | |||||||||||||||||
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||||||||||||||
| Net income | $ | 187,494 | $ | 119,555 | |||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||||||||
| Depreciation and amortization | 50,808 | 48,527 | |||||||||||||||
| Amortization of deferred financing costs | 99 | 101 | |||||||||||||||
| Deferred income taxes | (40,116) | 7,498 | |||||||||||||||
| Stock-based compensation | 61,798 | 33,548 | |||||||||||||||
| Loss (gain) on disposal of assets | 285 | (349) | |||||||||||||||
| Change in fair value of contingent consideration | (2,800) | (2,000) | |||||||||||||||
| Provisions for inventory and receivables reserves | (1,438) | 6,297 | |||||||||||||||
| Unrealized gains on marketable securities | (7,471) | (3,722) | |||||||||||||||
| Changes in operating assets and liabilities: | |||||||||||||||||
| Trade accounts receivable | (12,484) | (18,347) | |||||||||||||||
| Accounts payable (receivable) - other | 2,226 | (2,668) | |||||||||||||||
| Inventories | (75,150) | (4,471) | |||||||||||||||
| Prepaid expenses and other assets | (23,263) | (19,450) | |||||||||||||||
| Trade accounts payable | 11,958 | (4,348) | |||||||||||||||
| Due to/from related parties | 18,326 | (659) | |||||||||||||||
| Accrued expenses and other current and long-term liabilities | 22,934 | (3,383) | |||||||||||||||
| Net cash provided by operating activities | 193,206 | 156,129 | |||||||||||||||
| CASH FLOWS FROM INVESTING ACTIVITIES: | |||||||||||||||||
| Purchases of property, plant and equipment | (79,775) | (69,941) | |||||||||||||||
| Acquisition of business, net of cash acquired | (19,921) | (14,549) | |||||||||||||||
| Proceeds from sales of property, plant and equipment | — | 27,408 | |||||||||||||||
| Investments in marketable securities | — | (9,189) | |||||||||||||||
| Net cash used in investing activities | (99,696) | (66,271) | |||||||||||||||
| CASH FLOWS FROM FINANCING ACTIVITIES: | |||||||||||||||||
| Loans made to related party | (7,500) | (7,500) | |||||||||||||||
| Receipts on related party notes receivable | 2,812 | — | |||||||||||||||
| Proceeds from issuance of common stock under equity award and purchase plans less payments for taxes related to net share settlement of equity awards | (15,268) | 2,193 | |||||||||||||||
| Dividends paid to non-controlling interest | (42) | — | |||||||||||||||
| Net cash used in by financing activities | (19,998) | (5,307) | |||||||||||||||
| Effect of exchange rate changes on Cash and cash equivalents and Restricted cash | (4,606) | 1,373 | |||||||||||||||
| Net increase in Cash and cash equivalents and Restricted cash | 68,906 | 85,924 | |||||||||||||||
| Cash and cash equivalents and Restricted cash at beginning of period | 289,799 | 203,875 | |||||||||||||||
| CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AT END OF PERIOD: | $ | 358,705 | $ | 289,799 | |||||||||||||
| RECONCILIATION OF CASH AND CASH EQUIVALENTS AND RESTRICTED CASH: | |||||||||||||||||
| Cash and cash equivalents at beginning of period | $ | 282,383 | $ | 197,214 | |||||||||||||
| Restricted cash at beginning of period | 7,416 | 6,661 | |||||||||||||||
| Cash and cash equivalents and Restricted cash at beginning of period | $ | 289,799 | $ | 203,875 | |||||||||||||
| Cash and cash equivalents at end of period | 351,576 | 282,383 | |||||||||||||||
| Restricted cash at end of period | 7,129 | 7,416 | |||||||||||||||
| Cash and cash equivalents and Restricted cash at end of period | $ | 358,705 | $ | 289,799 | |||||||||||||
Non-GAAP Financial Measures
In addition to the measures presented in our consolidated financial statements, we regularly review other measures, defined as non-GAAP financial measures by the SEC, to evaluate our business, measure our performance, identify trends, prepare financial forecasts and make strategic decisions. The key measures we consider are non-GAAP Gross Profit, non-GAAP Gross Margin, non-GAAP Operating Expenses, non-GAAP Operating Income, non-GAAP Operating Margin, non-GAAP Profit before Tax, non-GAAP Provision for Income Tax, non-GAAP Net Income, non-GAAP Net Income per Share, EBITDA, Adjusted EBITDA and Adjusted EBITDA margin (collectively, the “Non-GAAP Financial Measures”). These Non-GAAP Financial Measures provide supplemental information regarding our operating performance on a non-GAAP basis that excludes certain gains, losses and charges of a non-cash nature or that occur relatively infrequently and/or that management considers to be unrelated to our core operations, and in the case of non-GAAP Provision for Income Tax, management believes that this non-GAAP measure of income taxes provides it with the ability to evaluate the non-GAAP Provision for Income Taxes across different reporting periods on a consistent basis, independent of special items and discrete items, which may vary in size and frequency. These Non-GAAP Financial Measures are used by both management and our board of directors, together with the comparable GAAP information, in evaluating our current performance and planning our future business activities.
The Non-GAAP Financial Measures are supplemental measures of our performance that are neither required by, nor presented in accordance with, GAAP. These Non-GAAP Financial Measures should not be considered as substitutes for GAAP financial measures such as gross profit, gross margin, net income or any other performance measures derived in accordance with GAAP. Also, in the future we may incur expenses or charges such as those being adjusted in the calculation of these Non-GAAP Financial Measures. Our presentation of these Non-GAAP Financial Measures should not be construed as an inference that future results will be unaffected by unusual or nonrecurring items. These non-GAAP measures exclude costs related to acquisition and related integration expenses, amortization of acquired intangible assets, stock-based compensation, restructuring actions, related party activities and other non-operational costs such as the impact of COVID 19.
Non-GAAP Provision for Income Tax
In calculating non-GAAP Provision for Income Tax, we have added back the following to GAAP Income Tax Provision:
•Tax effect of adjustments to GAAP results—Represents the estimated income tax effect of the adjustments to non-GAAP Profit Before Tax described above and elimination of discrete tax adjustments.
| Three-Month Period Ended | Fiscal Year Ended | |||||||||||||||||||||||||||||||
| March 31, 2023 | December 23, 2022 | March 25, 2022 | March 31, 2023 | March 25, 2022 | ||||||||||||||||||||||||||||
| (Dollars in thousands) | ||||||||||||||||||||||||||||||||
| Reconciliation of Non-GAAP Gross Profit | ||||||||||||||||||||||||||||||||
| GAAP Gross Profit | $ | 153,089 | $ | 142,594 | $ | 109,603 | $ | 546,079 | $ | 407,460 | ||||||||||||||||||||||
| Voxtel inventory impairment | — | — | — | — | 3,106 | |||||||||||||||||||||||||||
| Stock-based compensation | 1,978 | 1,156 | 1,184 | 5,090 | 3,176 | |||||||||||||||||||||||||||
| AMTC Facility consolidation one-time costs | — | — | — | — | 144 | |||||||||||||||||||||||||||
| Amortization of acquisition-related intangible assets | 627 | 589 | 273 | 1,867 | 1,092 | |||||||||||||||||||||||||||
| COVID-19 related expenses | — | — | 296 | — | 1,092 | |||||||||||||||||||||||||||
| Total Non-GAAP Adjustments | $ | 2,605 | $ | 1,745 | $ | 1,753 | $ | 6,957 | $ | 8,610 | ||||||||||||||||||||||
| Non-GAAP Gross Profit | $ | 155,694 | $ | 144,339 | $ | 111,356 | $ | 553,036 | $ | 416,070 | ||||||||||||||||||||||
| Non-GAAP Gross Margin | 57.8% | 58.0% | 55.6% | 56.8% | 54.1% | |||||||||||||||||||||||||||
| Three-Month Period Ended | Fiscal Year Ended | |||||||||||||||||||||||||||||||
| March 31, 2023 | December 23, 2022 | March 25, 2022 | March 31, 2023 | March 25, 2022 | ||||||||||||||||||||||||||||
| (Dollars in thousands) | ||||||||||||||||||||||||||||||||
| Reconciliation of Non-GAAP Operating Expenses | ||||||||||||||||||||||||||||||||
| GAAP Operating Expenses | $ | 89,985 | $ | 76,966 | $ | 79,354 | $ | 342,772 | $ | 270,810 | ||||||||||||||||||||||
| Research and Development Expenses | ||||||||||||||||||||||||||||||||
| GAAP Research and Development Expenses | 41,833 | 39,593 | 32,432 | 150,850 | 121,873 | |||||||||||||||||||||||||||
| Stock-based compensation | 3,483 | 3,174 | 1,119 | 9,496 | 3,933 | |||||||||||||||||||||||||||
| AMTC Facility consolidation one-time costs | — | — | — | — | 2 | |||||||||||||||||||||||||||
| COVID-19 related expenses | — | — | 3 | — | 23 | |||||||||||||||||||||||||||
| Transaction fees | — | 1 | 5 | 404 | 5 | |||||||||||||||||||||||||||
| Severance | 72 | — | — | 72 | — | |||||||||||||||||||||||||||
| Non-GAAP Research and Development Expenses | 38,278 | 36,418 | 31,305 | 140,878 | 117,910 | |||||||||||||||||||||||||||
| Selling, General and Administrative Expenses | ||||||||||||||||||||||||||||||||
| GAAP Selling, General and Administrative Expenses | 48,252 | 37,373 | 46,822 | 194,722 | 150,937 | |||||||||||||||||||||||||||
| Stock-based compensation | 5,095 | 4,572 | 12,598 | 47,212 | 26,439 | |||||||||||||||||||||||||||
| AMTC Facility consolidation one-time costs | 124 | 291 | 74 | 601 | 657 | |||||||||||||||||||||||||||
| Amortization of acquisition-related intangible assets | 22 | 23 | 22 | 90 | 90 | |||||||||||||||||||||||||||
| COVID-19 related expenses | — | — | 215 | — | 1,503 | |||||||||||||||||||||||||||
| Indirect transaction tax | 944 | — | — | 944 | — | |||||||||||||||||||||||||||
| Transaction fees | 644 | 35 | 384 | 2,339 | 1,498 | |||||||||||||||||||||||||||
| Sanken agreement termination fee | 5,000 | — | — | 5,000 | — | |||||||||||||||||||||||||||
| Severance | 368 | — | — | 4,554 | 746 | |||||||||||||||||||||||||||
| Non-GAAP Selling, General and Administrative Expenses | 36,055 | 32,452 | 33,529 | 133,982 | 120,004 | |||||||||||||||||||||||||||
| Change in fair value of contingent consideration | (100) | — | 100 | (2,800) | (2,000) | |||||||||||||||||||||||||||
| Total Non-GAAP Adjustments | 15,652 | 8,096 | 14,520 | 67,912 | 32,896 | |||||||||||||||||||||||||||
| Non-GAAP Operating Expenses | $ | 74,333 | $ | 68,870 | $ | 64,834 | $ | 274,860 | $ | 237,914 | ||||||||||||||||||||||
| Three-Month Period Ended | Fiscal Year Ended | |||||||||||||||||||||||||||||||
| March 31, 2023 | December 23, 2022 | March 25, 2022 | March 31, 2023 | March 25, 2022 | ||||||||||||||||||||||||||||
| (Dollars in thousands) | ||||||||||||||||||||||||||||||||
| Reconciliation of Non-GAAP Operating Income | ||||||||||||||||||||||||||||||||
| GAAP Operating Income | $ | 63,104 | $ | 65,628 | $ | 30,249 | $ | 203,307 | $ | 136,650 | ||||||||||||||||||||||
| Voxtel inventory impairment | — | — | — | — | 3,106 | |||||||||||||||||||||||||||
| Stock-based compensation | 10,556 | 8,902 | 14,901 | 61,798 | 33,548 | |||||||||||||||||||||||||||
| AMTC Facility consolidation one-time costs | 124 | 291 | 74 | 601 | 803 | |||||||||||||||||||||||||||
| Amortization of acquisition-related intangible assets | 649 | 612 | 295 | 1,957 | 1,182 | |||||||||||||||||||||||||||
| COVID-19 related expenses | — | — | 514 | — | 2,618 | |||||||||||||||||||||||||||
| Change in fair value of contingent consideration | (100) | — | 100 | (2,800) | (2,000) | |||||||||||||||||||||||||||
| Indirect transaction tax | 944 | — | — | 944 | — | |||||||||||||||||||||||||||
| Transaction fees | 644 | 36 | 389 | 2,743 | 1,503 | |||||||||||||||||||||||||||
| Sanken agreement termination fee | 5,000 | — | — | 5,000 | — | |||||||||||||||||||||||||||
| Severance | 440 | — | — | 4,626 | 746 | |||||||||||||||||||||||||||
| Total Non-GAAP Adjustments | $ | 18,257 | $ | 9,841 | $ | 16,273 | $ | 74,869 | $ | 41,506 | ||||||||||||||||||||||
| Non-GAAP Operating Income | $ | 81,361 | $ | 75,469 | $ | 46,522 | $ | 278,176 | $ | 178,156 | ||||||||||||||||||||||
| Non-GAAP Operating Margin (% of net sales) | 30.2% | 30.3% | 23.2% | 28.6% | 23.2% | |||||||||||||||||||||||||||
| Three-Month Period Ended | Fiscal Year Ended | |||||||||||||||||||||||||||||||
| March 31, 2023 | December 23, 2022 | March 25, 2022 | March 31, 2023 | March 25, 2022 | ||||||||||||||||||||||||||||
| (Dollars in thousands) | ||||||||||||||||||||||||||||||||
| Reconciliation of EBITDA and Adjusted EBITDA | ||||||||||||||||||||||||||||||||
| GAAP Net Income | $ | 62,012 | $ | 64,551 | $ | 25,652 | $ | 187,494 | $ | 119,555 | ||||||||||||||||||||||
| Interest expense | 755 | 613 | 418 | 2,336 | 2,499 | |||||||||||||||||||||||||||
| Interest income | (580) | (360) | (1,125) | (1,724) | (1,442) | |||||||||||||||||||||||||||
| Income tax provision | 5,909 | 7,540 | 4,504 | 23,852 | 21,191 | |||||||||||||||||||||||||||
| Depreciation & amortization | 14,103 | 12,580 | 12,006 | 50,808 | 48,527 | |||||||||||||||||||||||||||
| EBITDA | $ | 82,199 | $ | 84,924 | $ | 41,455 | $ | 262,766 | $ | 190,330 | ||||||||||||||||||||||
| Non-core (gain) loss on sale of equipment | (2) | 37 | 1 | 285 | (349) | |||||||||||||||||||||||||||
| Voxtel inventory impairment | — | — | — | — | 3,106 | |||||||||||||||||||||||||||
| Foreign currency translation loss (gain) | 1,617 | (407) | 513 | (980) | 568 | |||||||||||||||||||||||||||
| (Loss) income in earnings of equity investment | 703 | (2,190) | (215) | 406 | (1,007) | |||||||||||||||||||||||||||
| Unrealized (gains) losses on investments | (7,476) | (3,453) | 760 | (7,471) | (3,722) | |||||||||||||||||||||||||||
| Stock-based compensation | 10,556 | 8,902 | 14,901 | 61,798 | 33,548 | |||||||||||||||||||||||||||
| AMTC Facility consolidation one-time costs | 124 | 291 | 74 | 601 | 803 | |||||||||||||||||||||||||||
| COVID-19 related expenses | — | — | 514 | — | 2,618 | |||||||||||||||||||||||||||
| Change in fair value of contingent consideration | (100) | — | 100 | (2,800) | (2,000) | |||||||||||||||||||||||||||
| Indirect transaction tax | 944 | — | — | 944 | — | |||||||||||||||||||||||||||
| Transaction fees | 644 | 36 | 389 | 2,743 | 1,503 | |||||||||||||||||||||||||||
| Sanken agreement termination fee | 5,000 | — | — | 5,000 | — | |||||||||||||||||||||||||||
| Severance | 440 | — | — | 4,626 | 746 | |||||||||||||||||||||||||||
| Adjusted EBITDA | $ | 94,649 | $ | 88,140 | $ | 58,492 | $ | 327,918 | $ | 226,144 | ||||||||||||||||||||||
| Adjusted EBITDA Margin (% of net sales) | 35.1% | 35.4% | 29.2% | 33.7% | 29.4% | |||||||||||||||||||||||||||
| Three-Month Period Ended | Fiscal Year Ended | |||||||||||||||||||||||||||||||
| March 31, 2023 | December 23, 2022 | March 25, 2022 | March 31, 2023 | March 25, 2022 | ||||||||||||||||||||||||||||
| (Dollars in thousands) | ||||||||||||||||||||||||||||||||
| Reconciliation of Non-GAAP Profit before Tax | ||||||||||||||||||||||||||||||||
| GAAP Income before Income Taxes | $ | 67,921 | $ | 72,091 | $ | 30,156 | $ | 211,346 | $ | 140,746 | ||||||||||||||||||||||
| Non-core (gain) loss on sale of equipment | (2) | 37 | 1 | 285 | (349) | |||||||||||||||||||||||||||
| Voxtel inventory impairment | — | — | — | — | 3,106 | |||||||||||||||||||||||||||
| Foreign currency translation loss (gain) | 1,617 | (407) | 513 | (980) | 568 | |||||||||||||||||||||||||||
| (Loss) income in earnings of equity investment | 703 | (2,190) | (215) | 406 | (1,007) | |||||||||||||||||||||||||||
| Unrealized (gains) losses on investments | (7,476) | (3,453) | 760 | (7,471) | (3,722) | |||||||||||||||||||||||||||
| Stock-based compensation | 10,556 | 8,902 | 14,901 | 61,798 | 33,548 | |||||||||||||||||||||||||||
| AMTC Facility consolidation one-time costs | 124 | 291 | 74 | 601 | 803 | |||||||||||||||||||||||||||
| Amortization of acquisition-related intangible assets | 649 | 612 | 295 | 1,957 | 1,182 | |||||||||||||||||||||||||||
| COVID-19 related expenses | — | — | 514 | — | 2,618 | |||||||||||||||||||||||||||
| Change in fair value of contingent consideration | (100) | — | 100 | (2,800) | (2,000) | |||||||||||||||||||||||||||
| Indirect transaction tax | 944 | — | — | 944 | — | |||||||||||||||||||||||||||
| Transaction fees | 644 | 36 | 389 | 2,743 | 1,503 | |||||||||||||||||||||||||||
| Sanken agreement termination fee | 5,000 | — | — | 5,000 | — | |||||||||||||||||||||||||||
| Severance | 440 | — | — | 4,626 | 746 | |||||||||||||||||||||||||||
| Total Non-GAAP Adjustments | $ | 13,099 | $ | 3,828 | $ | 17,332 | $ | 67,109 | $ | 36,996 | ||||||||||||||||||||||
| Non-GAAP Profit before Tax | $ | 81,020 | $ | 75,919 | $ | 47,488 | $ | 278,455 | $ | 177,742 | ||||||||||||||||||||||
| Three-Month Period Ended | Fiscal Year Ended | |||||||||||||||||||||||||||||||
| March 31, 2023 | December 23, 2022 | March 25, 2022 | March 31, 2023 | March 25, 2022 | ||||||||||||||||||||||||||||
| (Dollars in thousands) | ||||||||||||||||||||||||||||||||
| Reconciliation of Non-GAAP Provision for Income Taxes | ||||||||||||||||||||||||||||||||
| GAAP Income Tax Provision | $ | 5,909 | $ | 7,540 | $ | 4,504 | $ | 23,852 | $ | 21,191 | ||||||||||||||||||||||
| GAAP effective tax rate | 8.7% | 10.5% | 14.9% | 11.3% | 15.1% | |||||||||||||||||||||||||||
| Tax effect of adjustments to GAAP results | 3,509 | (461) | 2,817 | 7,285 | 6,415 | |||||||||||||||||||||||||||
| Non-GAAP Provision for Income Taxes | $ | 9,418 | $ | 7,079 | $ | 7,321 | $ | 31,137 | $ | 27,606 | ||||||||||||||||||||||
| Non-GAAP effective tax rate | 11.6% | 9.3% | 15.4% | 11.2% | 15.5% | |||||||||||||||||||||||||||
| Three-Month Period Ended | Fiscal Year Ended | |||||||||||||||||||||||||||||||
| March 31, 2023 | December 23, 2022 | March 25, 2022 | March 31, 2023 | March 25, 2022 | ||||||||||||||||||||||||||||
| (Dollars in thousands) | ||||||||||||||||||||||||||||||||
| Reconciliation of Non-GAAP Net Income | ||||||||||||||||||||||||||||||||
| GAAP Net Income | $ | 62,012 | $ | 64,551 | $ | 25,652 | $ | 187,494 | $ | 119,555 | ||||||||||||||||||||||
| GAAP Basic Earnings per Share | $ | 0.32 | $ | 0.34 | $ | 0.14 | $ | 0.98 | $ | 0.63 | ||||||||||||||||||||||
| GAAP Diluted Earnings per Share | $ | 0.32 | $ | 0.33 | $ | 0.13 | $ | 0.97 | $ | 0.62 | ||||||||||||||||||||||
| Non-core (gain) loss on sale of equipment | (2) | 37 | 1 | 285 | (349) | |||||||||||||||||||||||||||
| Voxtel inventory impairment | — | — | — | — | 3,106 | |||||||||||||||||||||||||||
| Foreign currency translation loss (gain) | 1,617 | (407) | 513 | (980) | 568 | |||||||||||||||||||||||||||
| (Loss) income in earnings of equity investment | 703 | (2,190) | (215) | 406 | (1,007) | |||||||||||||||||||||||||||
| Unrealized (gains) losses on investments | (7,476) | (3,453) | 760 | (7,471) | (3,722) | |||||||||||||||||||||||||||
| Stock-based compensation | 10,556 | 8,902 | 14,901 | 61,798 | 33,548 | |||||||||||||||||||||||||||
| AMTC Facility consolidation one-time costs | 124 | 291 | 74 | 601 | 803 | |||||||||||||||||||||||||||
| Amortization of acquisition-related intangible assets | 649 | 612 | 295 | 1,957 | 1,182 | |||||||||||||||||||||||||||
| COVID-19 related expenses | — | — | 514 | — | 2,618 | |||||||||||||||||||||||||||
| Change in fair value of contingent consideration | (100) | — | 100 | (2,800) | (2,000) | |||||||||||||||||||||||||||
| Indirect transaction tax | 944 | — | — | 944 | — | |||||||||||||||||||||||||||
| Transaction fees | 644 | 36 | 389 | 2,743 | 1,503 | |||||||||||||||||||||||||||
| Sanken agreement termination fee | 5,000 | — | — | 5,000 | — | |||||||||||||||||||||||||||
| Severance | 440 | — | — | 4,626 | 746 | |||||||||||||||||||||||||||
| Tax effect of adjustments to GAAP results | (3,509) | 461 | (2,817) | (7,285) | (6,415) | |||||||||||||||||||||||||||
| Non-GAAP Net Income | $ | 71,602 | $ | 68,840 | $ | 40,167 | $ | 247,318 | $ | 150,136 | ||||||||||||||||||||||
| Basic weighted average common shares | 191,519,850 | 191,328,538 | 189,997,738 | 191,197,452 | 189,748,427 | |||||||||||||||||||||||||||
| Diluted weighted average common shares | 194,993,241 | 193,935,908 | 192,125,252 | 193,688,102 | 191,811,205 | |||||||||||||||||||||||||||
| Non-GAAP Basic Earnings per Share | $ | 0.37 | $ | 0.36 | $ | 0.21 | $ | 1.29 | $ | 0.79 | ||||||||||||||||||||||
| Non-GAAP Diluted Earnings per Share | $ | 0.37 | $ | 0.35 | $ | 0.21 | $ | 1.28 | $ | 0.78 | ||||||||||||||||||||||
Investor Contact:
Jalene Hoover
VP of Investor Relations & Corporate Communications
+1 (512) 751-6526
jhoover@allegromicro.com